AP - A Silicon Valley gene-testing startup is responding to criticism that the tests could spur bad health-care choices by teaming up for a broad study of how the results affect behavior.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.